Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa.
Rathner A, Rathner P, Friedrich A, Wießner M, Kitzler CM, Schernthaner J, Karl T, Krauß J, Lottspeich F, Mewes W, Hintner H, Bauer JW, Breitenbach M, Müller N, Breitenbach-Koller H, von Hagen J.
Rathner A, et al. Among authors: von hagen j.
Skin Pharmacol Physiol. 2021;34(4):167-182. doi: 10.1159/000513260. Epub 2021 Apr 6.
Skin Pharmacol Physiol. 2021.
PMID: 33823521